NASDAQ:CRSP   CRISPR Therapeutics AG
Long CRSP. Best case scenario if markets are cooperate.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.